Plus Therapeutics Grants 20,000 Options at $7.30 and 20,000 RSUs to New CDO
Plus Therapeutics granted Dr. Eric J. Daniels options for 20,000 common shares at a $7.30 exercise price and 20,000 restricted stock units when he joined on April 20, 2026. Options vest over four years and RSUs vest over three after compensation committee approval under Nasdaq Listing Rule 5635(c)(4).
1. Inducement Awards Details
On April 20, 2026, Plus Therapeutics granted Dr. Eric J. Daniels inducement awards under its 2015 New Employee Incentive Plan, as amended. The awards include options to purchase 20,000 common shares at a $7.30 exercise price and 20,000 restricted stock units, designed to attract him as Chief Development Officer.
2. Vesting Schedule and Regulatory Approval
The stock options carry a 10-year term and vest over four years with 25% vesting after one year and monthly vesting thereafter, while the RSUs vest over three years with quarterly installments. Both awards were approved by the compensation committee in compliance with Nasdaq Listing Rule 5635(c)(4).